Biosante Pharmaceuticals Aktie
64,00
EUR
-1,50
EUR
-2,29
%
74,22
USD
-1,64
USD
-2,16
%
Werbung
Biosante Pharmaceuticals Aktie Analyse
| 24.05.16 | Biosante Pharmaceuticals Hold | Standpoint Research | |
| 04.08.15 | Biosante Pharmaceuticals Neutral | ROTH Capital Partners, LLC | |
| 15.07.15 | Biosante Pharmaceuticals Neutral | ROTH Capital Partners, LLC | |
| 18.05.15 | Biosante Pharmaceuticals Neutral | ROTH Capital Partners, LLC | |
| 10.04.15 | Biosante Pharmaceuticals Neutral | ROTH Capital Partners, LLC |
Werbung
Werbung